Home | Business News | Browse by Publication | P | PR Newswire

Atrium Medical Corporation Receives FDA Approval for a New Vascular Implant Technology - FLIXENE(TM).

Publication: PR Newswire
Publication Date: 24-APR-06
Format: Online
Delivery: Immediate Online Access

Article Excerpt
HUDSON, N.H., April 24 /PRNewswire/ -- Atrium Medical Corporation announced today that it has received US FDA 510(k) marketing clearance for a new vascular product called FLIXENE. Indicated for vascular access and arterial vascular reconstruction, FLIXENE vascular grafts offer the discriminating surgeon an exciting new alternative to traditional 20...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
Leading Media and Entertainment Companies Embrace Isilon IQ to Acceler..., April 24, 2006
Clear Channel Deploys Isilon IQ to Streamline Operations for Its Globa..., April 24, 2006
Family IV Feature Package., April 24, 2006
Curious Software's Traffic Presenter Showcases Inrix's Real-Time and P..., April 24, 2006
AnalogicTech Expands DC/DC Converter Product Family., April 24, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.